These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 23673116)

  • 1. Differential expression of the RNA-binding motif protein 3 in human astrocytoma.
    Zhang HT; Zhang ZW; Xue JH; Kong HB; Liu AJ; Li SC; Liu YX; Xu DG
    Chin Med J (Engl); 2013; 126(10):1948-52. PubMed ID: 23673116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue thioredoxin reductase-1 expression in astrocytomas of different grades.
    Esen H; Erdi F; Kaya B; Feyzioglu B; Keskin F; Demir LS
    J Neurooncol; 2015 Feb; 121(3):451-8. PubMed ID: 25391969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positive correlation between the expression of X-chromosome RBM genes (RBMX, RBM3, RBM10) and the proapoptotic Bax gene in human breast cancer.
    Martínez-Arribas F; Agudo D; Pollán M; Gómez-Esquer F; Díaz-Gil G; Lucas R; Schneider J
    J Cell Biochem; 2006 Apr; 97(6):1275-82. PubMed ID: 16552754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of gemistocytes in astrocytoma progression.
    Watanabe K; Tachibana O; Yonekawa Y; Kleihues P; Ohgaki H
    Lab Invest; 1997 Feb; 76(2):277-84. PubMed ID: 9042164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Grade-specific expression of insulin-like growth factor-binding proteins-2, -3, and -5 in astrocytomas: IGFBP-3 emerges as a strong predictor of survival in patients with newly diagnosed glioblastoma.
    Santosh V; Arivazhagan A; Sreekanthreddy P; Srinivasan H; Thota B; Srividya MR; Vrinda M; Sridevi S; Shailaja BC; Samuel C; Prasanna KV; Thennarasu K; Balasubramaniam A; Chandramouli BA; Hegde AS; Somasundaram K; Kondaiah P; Rao MR
    Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1399-408. PubMed ID: 20501753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of tenascin-C in various human brain tumors and its relevance for survival in patients with astrocytoma.
    Leins A; Riva P; Lindstedt R; Davidoff MS; Mehraein P; Weis S
    Cancer; 2003 Dec; 98(11):2430-9. PubMed ID: 14635078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tenascin-C expression relates to clinicopathological features in pilocytic and diffuse astrocytomas.
    Maris C; Rorive S; Sandras F; D'Haene N; Sadeghi N; Bièche I; Vidaud M; Decaestecker C; Salmon I
    Neuropathol Appl Neurobiol; 2008 Jun; 34(3):316-29. PubMed ID: 17983425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of MG-160, a FGF binding medial Golgi sialoglycoprotein, in brain tumors: an index of malignancy in astrocytomas.
    Yamaguchi F; Morrison RS; Gonatas NK; Takahashi H; Sugisaki Y; Teramoto A
    Int J Oncol; 2003 May; 22(5):1045-9. PubMed ID: 12684670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of the tumor suppressor A-kinase anchor protein 12 in human diffuse and pilocytic astrocytomas is regulated by promoter methylation.
    Goeppert B; Schmidt CR; Geiselhart L; Dutruel C; Capper D; Renner M; Vogel MN; Zachskorn C; Zinke J; Campos B; Schmezer P; Popanda O; Wick W; Weller M; Meyermann R; Schittenhelm J; Harter PN; Simon P; Weichert W; Schirmacher P; Plass C; Mittelbronn M
    J Neuropathol Exp Neurol; 2013 Oct; 72(10):933-41. PubMed ID: 24042196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the distinctive biological characteristics of pilocytic and low-grade diffuse astrocytomas using microarray gene expression profiles.
    Rorive S; Maris C; Debeir O; Sandras F; Vidaud M; Bièche I; Salmon I; Decaestecker C
    J Neuropathol Exp Neurol; 2006 Aug; 65(8):794-807. PubMed ID: 16896313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promoter hypermethylation-mediated down-regulation of CXCL12 in human astrocytoma.
    Zhou W; Jiang Z; Song X; Liu Y; Wen P; Guo Y; Xu F; Kong L; Zhang P; Han A; Yu J
    J Neurosci Res; 2008 Oct; 86(13):3002-10. PubMed ID: 18512766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of frizzled 9 in astrocytomas.
    Zhang Z; Schittenhelm J; Guo K; Bühring HJ; Trautmann K; Meyermann R; Schluesener HJ
    Neuropathol Appl Neurobiol; 2006 Dec; 32(6):615-24. PubMed ID: 17083476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MIB-1 labeling index in astrocytic tumors--a clinicopathologic study.
    Neder L; Colli BO; Machado HR; Carlotti CG; Santos AC; Chimelli L
    Clin Neuropathol; 2004; 23(6):262-70. PubMed ID: 15584210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apoptosis and proliferation markers in diffusely infiltrating astrocytomas: profiling of 17 molecules.
    Liu X; Chen N; Wang X; He Y; Chen X; Huang Y; Yin W; Zhou Q
    J Neuropathol Exp Neurol; 2006 Sep; 65(9):905-13. PubMed ID: 16957584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of podoplanin in malignant astrocytic tumors as a novel molecular marker of malignant progression.
    Mishima K; Kato Y; Kaneko MK; Nishikawa R; Hirose T; Matsutani M
    Acta Neuropathol; 2006 May; 111(5):483-8. PubMed ID: 16596424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of ubiquitin-conjugating enzyme E2C/UbcH10 in astrocytic tumors.
    Jiang L; Huang CG; Lu YC; Luo C; Hu GH; Liu HM; Chen JX; Han HX
    Brain Res; 2008 Mar; 1201():161-6. PubMed ID: 18331723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of sphingosine kinase-1 expression in human astrocytomas progression and overall patient survival.
    Li J; Guan HY; Gong LY; Song LB; Zhang N; Wu J; Yuan J; Zheng YJ; Huang ZS; Li M
    Clin Cancer Res; 2008 Nov; 14(21):6996-7003. PubMed ID: 18980995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of aquaporin8 in human astrocytomas: correlation with pathologic grade.
    Zhu SJ; Wang KJ; Gan SW; Xu J; Xu SY; Sun SQ
    Biochem Biophys Res Commun; 2013 Oct; 440(1):168-72. PubMed ID: 24055034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced expression of PDCD5 is associated with high-grade astrocytic gliomas.
    Li H; Wang Q; Gao F; Zhu F; Wang X; Zhou C; Liu C; Chen Y; Ma C; Sun W; Zhang L
    Oncol Rep; 2008 Sep; 20(3):573-9. PubMed ID: 18695908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of p57(KIP2) potently blocks the growth of human astrocytomas and induces cell senescence.
    Tsugu A; Sakai K; Dirks PB; Jung S; Weksberg R; Fei YL; Mondal S; Ivanchuk S; Ackerley C; Hamel PA; Rutka JT
    Am J Pathol; 2000 Sep; 157(3):919-32. PubMed ID: 10980131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.